Nachrichten zur Viatris Aktie

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of…

Viatris Inc. (VTRS) Barclays 27th Annual Global Healthcare Conference (Transcript)

…

Whats in the Cards for Viatris Stock This Q4 Earnings?

VTRS Q4 results are likely to gain from new product launches in all major geographies.…

Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)

…

FDA restricts import of certain Viatris products due to plant violations By Investing.com

FDA restricts import of certain Viatris products due to plant violations…

Viatris Inc. (VTRS) Management Presents at Jefferies London Healthcare Conference (Transcript)

…

Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)

…

Theravances Q3 Loss Narrower Than Expected, Revenues Rise Y/Y

TBPH beats third-quarter estimates for both sales and earnings. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…

Viatris Inc. (VTRS): A Strategic Shift in Healthcare Investments

We recently published a list of 8 Stocks Under $20 To Invest In Now. In this article, we are going…

Aktienmarkt: Kurs der Viatris-Aktie im Minus (10,0972 €)

An der US-amerikanischen Börse notiert das Wertpapier von Viatris zur Stunde leichter. Der jüngste Kurs betrug 11,20 US-Dollar. An der…

US Biosimilar Market Research 2024-2028 Featuring Leading Players - Pfizer, Novartis, Amgen, Samsung Biologics, Celltrion, and Viatris

Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "US Biosimilar Market: Insights & Forecast (2024-2028)" report has been…

Viatris Inc. (VTRS) Q2 2024 Earnings Call Transcript

…

Theravance (TBPH) Q2 Loss Wider Than Expected, Revenues Rise Y/Y

Theravance (TBPH) misses second-quarter estimates on both fronts. Increased collaboration revenues from Viatris drive year-over-year top-line performance.…

Viatris Inc. (VTRS) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)

…

Viatris Inc. (VTRS) Presents at Jefferies 2024 Global Healthcare Conference (Transcript)

…

Global Topical Wound Agents Market Size To Exceed USD 3.7 Billion By 2033 | CAGR Of 6.89%

The Global Topical Wound Agents Market Size was valued at USD 1.9 Billion in 2023 and the Global Topical Wound…

Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference (Transcript)

…

Analyst Report: Viatris Inc

…

Viatris Inc. (VTRS) Q1 2024 Earnings Call Transcript

…

Inflation Reduction Act: A Bullish Catalyst For Viatris Inc.

…

Viatris Stock: Way Too Undervalued With $1 Billion Buyback Potential

…

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent By Reuters

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent…

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

FARMINGTON HILLS, Mich., April 01, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage biopharmaceutical company…